Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance
出版年份 2020 全文链接
标题
Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance
作者
关键词
Gene editing, CRISPR-Cas9, SLC35F2, YM155, Human pluripotent stem cells, Disease modeling
出版物
BIOMATERIALS
Volume 262, Issue -, Pages 120295
出版商
Elsevier BV
发表日期
2020-09-02
DOI
10.1016/j.biomaterials.2020.120295
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genome-wide target specificity of CRISPR RNA-guided adenine base editors
- (2019) Daesik Kim et al. NATURE BIOTECHNOLOGY
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- A Survey of Validation Strategies for CRISPR-Cas9 Editing
- (2018) Monica F. Sentmanat et al. Scientific Reports
- Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection
- (2018) Benjamin Steyer et al. Stem Cell Reports
- Intact wound repair activity of human mesenchymal stem cells after YM155 mediated selective ablation of undifferentiated human embryonic stem cells
- (2017) Keun-Tae Kim et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155
- (2017) Michael D. Nyquist et al. MOLECULAR CANCER RESEARCH
- Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis
- (2017) Young Cha et al. NATURE CELL BIOLOGY
- Marker-free coselection for CRISPR-driven genome editing in human cells
- (2017) Daniel Agudelo et al. NATURE METHODS
- CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
- (2017) Shengdar Q Tsai et al. NATURE METHODS
- Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels
- (2017) Mei Yi Sim et al. PLoS One
- PRMT8 Controls the Pluripotency and Mesodermal Fate of Human Embryonic Stem Cells By Enhancing the PI3K/AKT/SOX2 Axis
- (2017) Ho-Chang Jeong et al. STEM CELLS
- Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
- (2017) Branka Radic-Sarikas et al. Scientific Reports
- Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155
- (2017) Seok-Jin Kang et al. Stem Cell Research & Therapy
- CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
- (2017) Zhao Zhang et al. Molecular Therapy-Nucleic Acids
- Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection
- (2017) Katie A. Mitzelfelt et al. Stem Cell Reports
- An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells
- (2017) Yifang Xie et al. Scientific Reports
- Cas-analyzer: an online tool for assessing genome editing results using NGS data
- (2016) Jeongbin Park et al. BIOINFORMATICS
- Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions
- (2016) William T. Hendriks et al. Cell Stem Cell
- Induced Pluripotent Stem Cells Meet Genome Editing
- (2016) Dirk Hockemeyer et al. Cell Stem Cell
- Induced pluripotent stem cell technology: a decade of progress
- (2016) Yanhong Shi et al. NATURE REVIEWS DRUG DISCOVERY
- Pluripotent stem cells in disease modelling and drug discovery
- (2016) Yishai Avior et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders
- (2016) Aurelie Bedel et al. Stem Cells Translational Medicine
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- Efficient CRISPR-Cas9-Mediated Generation of Knockin Human Pluripotent Stem Cells Lacking Undesired Mutations at the Targeted Locus
- (2015) Florian T. Merkle et al. Cell Reports
- CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus
- (2015) HyunJun Kang et al. Molecular Therapy-Nucleic Acids
- A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells
- (2015) Zengrong Zhu et al. Stem Cell Reports
- An iCRISPR Platform for Rapid, Multiplexable, and Inducible Genome Editing in Human Pluripotent Stem Cells
- (2014) Federico González et al. Cell Stem Cell
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
- (2014) Georg E Winter et al. Nature Chemical Biology
- Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations
- (2014) Suresh Ramakrishna et al. Nature Communications
- High Mitochondrial Priming Sensitizes hESCs to DNA-Damage-Induced Apoptosis
- (2013) Julia C. Liu et al. Cell Stem Cell
- Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function
- (2013) Florian T. Merkle et al. Cell Stem Cell
- Integrating Human Pluripotent Stem Cells into Drug Development
- (2013) Sandra J. Engle et al. Cell Stem Cell
- Genome editing of human pluripotent stem cells to generate human cellular disease models
- (2013) K. Musunuru Disease Models & Mechanisms
- Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library
- (2013) Hiroko Koike-Yusa et al. NATURE BIOTECHNOLOGY
- Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
- (2013) Andrew S Lee et al. NATURE MEDICINE
- Inhibition of pluripotent stem cell-derived teratoma formation by small molecules
- (2013) M.-O. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures
- (2013) Stuart Avery et al. Stem Cell Reports
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- CCR5-Targeted Hematopoietic Stem Cell Gene Approaches for HIV Disease: Current Progress and Future Prospects
- (2012) Yu Lai Current Stem Cell Research & Therapy
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
- (2010) Nathalia Holt et al. NATURE BIOTECHNOLOGY
- Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
- (2010) Ilya Kupershmidt et al. PLoS One
- The Human Carnitine Transporter SLC22A16 Mediates High Affinity Uptake of the Anticancer Polyamine Analogue Bleomycin-A5
- (2009) Mustapha Aouida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started